Frances A Collichio

Frances A Collichio

UNVERIFIED PROFILE

Are you Frances A Collichio?   Register this Author

Register author
Frances A Collichio

Frances A Collichio

Publications by authors named "Frances A Collichio"

Are you Frances A Collichio?   Register this Author

21Publications

2278Reads

5Profile Views

Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.

Oncology 2019 Dec 3:1-5. Epub 2019 Dec 3.

Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000504578DOI Listing
December 2019

Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab.

Acta Oncol 2017 10 8;56(10):1327-1330. Epub 2017 May 8.

a Division of Hematology/Oncology , East Carolina University , Greenville , NC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2017.1324212DOI Listing
October 2017

Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance.

J Cancer Educ 2017 Sep;32(3):647-654

Division of Hematology/Oncology, University of Michigan Health System and Veterans Affairs Ann Arbor Health System, C345 Med Inn Building/SPC 5848, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-016-0993-6DOI Listing
September 2017

The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.

Anticancer Drugs 2017 07;28(6):669-675

aUNC Lineberger Comprehensive Cancer Center Departments of bRadiation Oncology cMedicine dNeurosurgery, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000497DOI Listing
July 2017

Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.

J Comput Assist Tomogr 2016 Sep-Oct;40(5):803-5

From the *Department of Radiology, New York University Medical Center, New York, NY; and †Division of Hematology and Oncology, Department of Medicine, UNC at Chapel Hill, Chapel Hill, NC; ‡Neuroradiology Section, Department of Radiology, The University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027959PMC
January 2017

Unanticipated hospital admissions during or soon after radiation therapy: Incidence and predictive factors.

Pract Radiat Oncol 2015 May-Jun;5(3):e245-53. Epub 2014 Sep 17.

Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2014.08.004DOI Listing
April 2016

Systematic review: surgery for patients with metastatic melanoma during active treatment with ipilimumab.

Am Surg 2014 Aug;80(8):805-10

Division of Surgical Oncology, Department of Surgery, Maine Medical Center, Portland, Maine, USA.

View Article

Download full-text PDF

Source
August 2014

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

J Clin Oncol 2013 Sep 17;31(26):3182-90. Epub 2013 Jun 17.

F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute; Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital; Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA; Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and Oregon Health & Science University, Portland, OR; Philip Friedlander, Mount Sinai Medical Center, New York, NY; Rene Gonzalez, University of Colorado Cancer Center, Aurora, CO; Jeffrey S. Weber, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Thomas F. Gajewski, University of Chicago, Chicago, IL; Steven J. O'Day, Beverly Hills Cancer Center, Beverly Hills, CA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Frances A. Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; and Marc S. Ernstoff, Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.7836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878082PMC
September 2013

Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer.

Clin Breast Cancer 2010 Dec;10(6):465-70

The Lineberger Comprehensive Cancer Center, and Division of Hematology/Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830095PMC
December 2010

How to organize a fellowship program: lessons learned and how to include accreditation council for graduate medical education competencies in the curriculum.

J Clin Oncol 2010 Aug 6;28(22):3659-67. Epub 2010 Jul 6.

Division of Hematology Oncology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.28.1964DOI Listing
August 2010

Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.

Cancer Chemother Pharmacol 2007 Oct 7;60(5):759-66. Epub 2007 Feb 7.

Department of Hematology/Oncology, Developmental Therapeutics Group Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0423-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860386PMC
October 2007

Concomitant pregnancy and breast cancer: options for systemic therapy.

Breast Dis 2005-2006;23:95-101

Department of Medicine, Division of Hematology-Oncology, The University of North Carolina School of Medicine, Chapel Hill, 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/bd-2006-23113DOI Listing
August 2006

Breaking bad news.

Integr Cancer Ther 2003 Mar;2(1):39-62

Institute for Integrative Cancer Research and Education, 1800 Sherman Ave., Suite 515, Evanston, IL 60201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1534735403251273DOI Listing
March 2003

Phase II study of low-dose infusional 5-fluorouracil and paclitaxel (Taxol) given every 2 weeks in metastatic breast cancer.

Am J Clin Oncol 2002 Apr;25(2):194-7

University of North Carolina, Chapel Hill, Chapel Hill, North Carolina 27599, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000421-200204000-00020DOI Listing
April 2002